AWS has announced the general availability of Amazon S3 Vectors, increasing per-index capacity forty-fold to 2 billion ...

But in the 1990s the virus that causes AIDS turned out to offer a solution. Researchers discovered how to strip away HIV’s destructive genes and repurpose it as a “lentiviral vector”—a tool to deliver ...

Thrust-vectoring makes impossible maneuvers possible. The huge, powerful jets can perform extremely tight turns that ...

According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

-Oral Presentation at ESGCT Highlights Potential of JCR’s Proprietary JUST-AAV Platform to Facilitate More Efficient Delivery While Reducing Liver Tropism- JCR Pharmaceuticals Co., Ltd. (TSE 4552; ...

-Oral Presentation at ESGCT Highlights Potential of JCR’s Proprietary JUST-AAV Platform to Facilitate More Efficient Delivery While Reducing Liver Tropism- HYOGO, Japan--(BUSINESS WIRE)--JCR ...

Apertura has licensed its novel TfR1 capsid (TfR1 CapX) to partners targeting CNS disorders TfR1 CapX enables broad brain distribution via intravenous dosing, meeting the urgent need for a ...

Currently, GenAns Biotech is conducting investigator-initiated trials for several gene therapies, including GA001 for ...